Ovarian dysgenesis 1
MONDO:0024463Also known as: ODG1, ovarian dysgenesis 1, XX gonadal dysgenesis, XXGD, gonadal dysgenesis, 20 type, gonadal dysgenesis, XX type, ovarian dysgenesis, hypergonadotropic, autosomal recessive, ovarian dysgenesis, hypergonadotropic, with normal karyotype
75 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
New IVF drug trial halted early: did it help embryo growth?
Disease control TerminatedThis early-stage trial tested whether adding the drug FE999302 to standard IVF hormones could increase the number of high-quality embryos in women undergoing fertility treatment. The study enrolled 310 women aged 18–40 with specific hormone levels. The trial was terminated early,…
Phase: PHASE1 • Sponsor: Ferring Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Timing of fertility drug may affect egg quality in IVF
Disease control TerminatedThis early-phase study looked at whether giving an extra fertility drug (FE 999302) at different times during ovarian stimulation could improve the number of good-quality embryos in women undergoing IVF. The trial included 106 women with high ovarian reserve and was stopped early…
Phase: PHASE1 • Sponsor: Ferring Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Does Dad's smoking harm fertility? new study investigates
Knowledge-focused TerminatedThis study looked at how a man's smoking habits might affect a couple's ability to have a baby. Researchers compared fertile and infertile couples, measuring smoking markers like carbon monoxide and cotinine in blood, semen, and hair. The goal was to understand if smoking damages…
Phase: NA • Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC